aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
jueves, 27 de agosto de 2015
Safe Healthcare | Hosted by CDC’s Division of Healthcare Quality PromotionSafe Healthcare | Blogs | CDC
“NARMS Now: Human Data” paints national picture of antibiotic resistance in foodborne bacteria
Have you ever wondered how antibiotic resistance in foodborne bacteria has changed over time? Take a look at CDC's Safe Healthcare blog to learn about NARMS Now, a new, interactive tool from the CDC that allows you to view trends in antibiotic resistance over the past two decades for four foodborne bacteria: Campylobacter, E. coli O157, Salmonella, and Shigella. NARMS Now contains human antibiotic resistance data from the National Antimicrobial Resistance Monitoring System (NARMS), a partnership among CDC, theFood and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), and state and local health departments.
Author: CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Wondering how antibiotic resistance in foodborne bacteria has changed over time? You’re in luck. With CDC’s new interactive tool, NARMS Now: Human Data, you can view trends in antibiotic resistance over the past two decades for four bacteria transmitted commonly through food: Campylobacter, E. coli Read More >
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >
CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care Read More >
No hay comentarios:
Publicar un comentario